Blackhill Capital Inc Abb Vie Inc. Transaction History

Blackhill Capital Inc

$1.73 Billion
Q3 2024

A detailed history of Blackhill Capital Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Blackhill Capital Inc holds 258,810 shares of ABBV stock, worth $46.4 Million. This represents 2.95% of its overall portfolio holdings.

Number of Shares

258,810

Previous 268,810 3.72%

Holding current value

$46.4 Million

Previous $46.1 Million 10.85%

% of portfolio

2.95%

Previous 2.87%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $1.64 Million - $1.99 Million	-10,000 Reduced 3.72%	258,810 $51.1 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $2.85 Million - $3.33 Million	18,400 Added 7.35%	268,810 $46.1 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $39,955 - $45,525	-250 Reduced 0.1%	250,410 $45.6 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $1.36 Million - $1.58 Million	-10,200 Reduced 3.91%	250,660 $37.4 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $318,024 - $395,760	-2,400 Reduced 0.91%	260,860 $35.1 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $535,057 - $616,198	3,700 Added 1.43%	263,260 $42 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $456,314 - $523,362	3,400 Added 1.33%	259,560 $34.8 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $220,192 - $279,936	-1,600 Reduced 0.62%	256,160 $39.2 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $791,879 - $982,500	6,000 Added 2.38%	257,760 $41.8 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $441,882 - $492,282	4,200 Added 1.7%	251,760 $28.4 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $30,690 - $33,786	300 Added 0.12%	247,560 $26.8 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $171,820 - $201,660	-2,000 Reduced 0.8%	247,260 $21.7 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $4.06 Million - $5.43 Million	55,290 Added 28.5%	249,260 $24.5 Million
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $25,800 - $39,116	400 Added 0.21%	193,970 $14.8 Million
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $750,152 - $938,600	10,400 Added 5.68%	193,570 $17.1 Million
Q3 2019 Nov 07, 2019	SELL	$62.98 - $75.72 $226,728 - $272,592	-3,600 Reduced 1.93%	183,170 $13.9 Million
Q1 2019 May 02, 2019	BUY	$77.14 - $90.79 $740,544 - $871,584	9,600 Added 5.42%	186,770 $15.1 Million
Q4 2018 Jan 31, 2019	SELL	$77.85 - $96.01 $263,911 - $325,473	-3,390 Reduced 1.88%	177,170 $16.3 Million
Q3 2018 Oct 24, 2018	SELL	$88.91 - $98.84 $17,782 - $19,768	-200 Reduced 0.11%	180,560 $17.1 Million
Q2 2018 Aug 06, 2018	SELL	$89.78 - $106.23 $1.07 Million - $1.26 Million	-11,900 Reduced 6.18%	180,760 $16.7 Million
Q1 2018 May 08, 2018	SELL	$92.01 - $123.21 $276,030 - $369,630	-3,000 Reduced 1.53%	192,660 $18.2 Million
Q4 2017 Feb 05, 2018	SELL	$89.56 - $98.21 $716,480 - $785,680	-8,000 Reduced 3.93%	195,660 $18.9 Million
Q3 2017 Nov 02, 2017	BUY	$69.85 - $89.22 $14.2 Million - $18.2 Million	203,660	203,660 $18.1 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackhill Capital Inc, based on Form 13F filings with the SEC.

News

Stay updated on Blackhill Capital Inc with notifications on news.

Account

Blackhill Capital Inc Abb Vie Inc. Transaction History